Human Genetics

, Volume 131, Issue 3, pp 373–391 | Cite as

Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing

  • Kathleen Askland
  • Cynthia Read
  • Chloe O’Connell
  • Jason H. Moore
Original Investigation

Abstract

Schizophrenia is a complex genetic disorder. Gene set-based analytic (GSA) methods have been widely applied for exploratory analyses of large, high-throughput datasets, but less commonly employed for biological hypothesis testing. Our primary hypothesis is that variation in ion channel genes contribute to the genetic susceptibility to schizophrenia. We applied Exploratory Visual Analysis (EVA), one GSA application, to analyze European-American (EA) and African-American (AA) schizophrenia genome-wide association study datasets for statistical enrichment of ion channel gene sets, comparing GSA results derived under three SNP-to-gene mapping strategies: (1) GENIC; (2) 500-Kb; (3) 2.5-Mb and three complimentary SNP-to-gene statistical reduction methods: (1) minimum p value (pMIN); (2) a novel method, proportion of SNPs per Gene with p values below a pre-defined α-threshold (PROP); and (3) the truncated product method (TPM). In the EA analyses, ion channel gene set(s) were enriched under all mapping and statistical approaches. In the AA analysis, ion channel gene set(s) were significantly enriched under pMIN for all mapping strategies and under PROP for broader mapping strategies. Less extensive enrichment in the AA sample may reflect true ethnic differences in susceptibility, sampling or case ascertainment differences, or higher dimensionality relative to sample size of the AA data. More consistent findings under broader mapping strategies may reflect enhanced power due to increased SNP inclusion, enhanced capture of effects over extended haplotypes or significant contributions from regulatory regions. While extensive pMIN findings may reflect gene size bias, the extent and significance of PROP and TPM findings suggest that common variation at ion channel genes may capture some of the heritability of schizophrenia.

References

  1. Abdi H (2007) The Bonferonni and Šidák corrections formultiple comparisons. In: Salkind N (ed) Encyclopedia of measurement and statistics. Sage, Thousand Oaks, CA, pp 1–9Google Scholar
  2. Abernethy DR, Soldatov NM (2002) Structure-functional diversity of human L-type Ca2+ channel: perspectives for new pharmacological targets. J Pharmacol Exp Ther 300:724–728PubMedCrossRefGoogle Scholar
  3. Ader C, Schneider R, Hornig S, Velisetty P, Wilson EM, Lange A, Giller K, Ohmert I, Martin-Eauclaire MF, Trauner D, Becker S, Pongs O, Baldus M (2008) A structural link between inactivation and block of a K+ channel. Nat Struct Mol Biol 15:605–612PubMedCrossRefGoogle Scholar
  4. Alaerts M, Del-Favero J (2009) Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future. Hum Mutat 30:1139–1152PubMedCrossRefGoogle Scholar
  5. Al-Shahrour F, Arbiza L, Dopazo H, Huerta-Cepas J, Minguez P, Montaner D, Dopazo J (2007) From genes to functional classes in the study of biological systems. BMC Bioinfor 8:114CrossRefGoogle Scholar
  6. Anderson PA, Greenberg RM (2001) Phylogeny of ion channels: clues to structure and function. Comp Biochem Physiol B Biochem Mol Biol 129:17–28PubMedCrossRefGoogle Scholar
  7. Angelino E, Brenner MP (2007) Excitability constraints on voltage-gated sodium channels. PLoS Comput Biol 3:1751–1760PubMedCrossRefGoogle Scholar
  8. Anselmi C, Carloni P, Torre V (2007) Origin of functional diversity among tetrameric voltage-gated channels. Proteins 66:136–146PubMedCrossRefGoogle Scholar
  9. Antonarakis SE, Blouin JL, Lasseter VK, Gehrig C, Radhakrishna U, Nestadt G, Housman DE, Kazazian HH, Kalman K, Gutman G, Fantino E, Chandy KG, Gargus JJ, Pulver AE (1999) Lack of linkage or association between schizophrenia and the polymorphic trinucleotide repeat within the KCNN3 gene on chromosome 1q21. Am J Med Genet 88:348–351PubMedCrossRefGoogle Scholar
  10. Ashcroft FM (2006) From molecule to malady. Nature 440:440–447PubMedCrossRefGoogle Scholar
  11. Ashwin C, Baron-Cohen S, Wheelwright S, O’Riordan M, Bullmore ET (2007) Differential activation of the amygdala and the ‘social brain’ during fearful face-processing in Asperger syndrome. Neuropsychologia 45:2–14PubMedCrossRefGoogle Scholar
  12. Askland K, Read C, Moore J (2009) Pathways-based analyses of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission. Hum Genet 125:63–79PubMedCrossRefGoogle Scholar
  13. Austin CP, Holder DJ, Ma L, Mixson LA, Caskey CT (1999) Mapping of hKCa3 to chromosome 1q21 and investigation of linkage of CAG repeat polymorphism to schizophrenia. Mol Psychiatry 4:261–266PubMedCrossRefGoogle Scholar
  14. Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182–217PubMedCrossRefGoogle Scholar
  15. Bigos KL, Mattay VS, Callicott JH, Straub RE, Vakkalanka R, Kolachana B, Hyde TM, Lipska BK, Kleinman JE, Weinberger DR (2010) Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch Gen Psychiatry 67:939–945PubMedCrossRefGoogle Scholar
  16. Booth JR, Burman DD, Meyer JR, Gitelman DR, Parrish TB, Mesulam MM (2002) Functional anatomy of intra- and cross-modal lexical tasks. Neuroimage 16:7–22PubMedCrossRefGoogle Scholar
  17. Borsotto M, Cavarec L, Bouillot M, Romey G, Macciardi F, Delaye A, Nasroune M, Bastucci M, Sambucy JL, Luan JJ, Charpagne A, Jouet V, Leger R, Lazdunski M, Cohen D, Chumakov I (2007) PP2A-Bgamma subunit and KCNQ2 K+ channels in bipolar disorder. Pharmacogenomics J 7:123–132PubMedCrossRefGoogle Scholar
  18. Bowen T, Guy CA, Craddock N, Cardno AG, Williams NM, Spurlock G, Murphy KC, Jones LA, Gray M, Sanders RD, McCarthy G, Chandy KG, Fantino E, Kalman K, Gutman GA, Gargus JJ, Williams J, McGuffin P, Owen MJ, O’Donovan MC (1998) Further support for an association between a polymorphic CAG repeat in the hKCa3 gene and schizophrenia. Mol Psychiatry 3:266–269PubMedCrossRefGoogle Scholar
  19. Bowen T, Williams N, Norton N, Spurlock G, Wittekindt OH, Morris-Rosendahl DJ, Williams H, Brzustowicz L, Hoogendoorn B, Zammit S, Jones G, Sanders RD, Jones LA, McCarthy G, Jones S, Bassett A, Cardno AG, Owen MJ, O’Donovan MC (2001) Mutation screening of the KCNN3 gene reveals a rare frameshift mutation. Mol Psychiatry 6:259–260PubMedCrossRefGoogle Scholar
  20. Breier A, Elman I, Goldstein DS (1998) Norepinephrine and schizophrenia: a new hypothesis for antipsychotic drug action. Adv Pharmacol 42:785–788PubMedCrossRefGoogle Scholar
  21. Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS (2000) Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21–q22. Science 288:678–682PubMedCrossRefGoogle Scholar
  22. Buchanan RW, Francis A, Arango C, Miller K, Lefkowitz DM, McMahon RP, Barta PE, Pearlson GD (2004) Morphometric assessment of the heteromodal association cortex in schizophrenia. Am J Psychiatry 161:322–331PubMedCrossRefGoogle Scholar
  23. Butler-Munro C, Coddington EJ, Shirley CH, Heyward PM (2010) Lithium modulates cortical excitability in vitro. Brain Res 1352:50–60PubMedCrossRefGoogle Scholar
  24. Camchong J, Dyckman KA, Chapman CE, Yanasak NE, McDowell JE (2006) Basal ganglia-thalamocortical circuitry disruptions in schizophrenia during delayed response tasks. Biol Psychiatry 60:235–241PubMedCrossRefGoogle Scholar
  25. Camerino DC, Desaphy JF, Tricarico D, Pierno S, Liantonio A (2008) Therapeutic approaches to ion channel diseases. Adv Genet 64:81–145PubMedCrossRefGoogle Scholar
  26. Cardno AG, Bowen T, Guy CA, Jones LA, McCarthy G, Williams NM, Murphy KC, Spurlock G, Gray M, Sanders RD, Craddock N, McGuffin P, Owen MJ, O’Donovan MC (1999) CAG repeat length in the hKCa3 gene and symptom dimensions in schizophrenia. Biol Psychiatry 45:1592–1596PubMedCrossRefGoogle Scholar
  27. Catterall WA, Few AP (2008) Calcium channel regulation and presynaptic plasticity. Neuron 59:882–901PubMedCrossRefGoogle Scholar
  28. Cerda O, Baek JH, Trimmer JS (2011) Mining recent brain proteomic databases for ion channel phosphosite nuggets. J Gen Physiol 137:3–16PubMedCrossRefGoogle Scholar
  29. Chahine M, Chatelier A, Babich O, Krupp JJ (2008) Voltage-gated sodium channels in neurological disorders. CNS Neurol Disord Drug Targets 7:144–158PubMedCrossRefGoogle Scholar
  30. Chandy KG, Fantino E, Wittekindt O, Kalman K, Tong LL, Ho TH, Gutman GA, Crocq MA, Ganguli R, Nimgaonkar V, Morris-Rosendahl DJ, Gargus JJ (1998) Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: a candidate for schizophrenia and bipolar disorder? Mol Psychiatry 3:32–37PubMedCrossRefGoogle Scholar
  31. Chen L, Zhang L, Zhao Y, Xu L, Shang Y, Wang Q, Li W, Wang H, Li X (2009) Prioritizing risk pathways: a novel association approach to searching for disease pathways fusing SNPs and pathways. Bioinformatics 25:237–242PubMedCrossRefGoogle Scholar
  32. Chowdari KV, Wood J, Ganguli R, Gottesman II, Nimgaonkar VL (2000) Lack of association between schizophrenia and a CAG repeat polymorphism of the hSKCa3 gene in a north eastern US sample. Mol Psychiatry 5:237–238PubMedCrossRefGoogle Scholar
  33. Corti C, Xuereb JH, Crepaldi L, Corsi M, Michielin F, Ferraguti F (2011) Altered levels of glutamatergic receptors and Na(+)/K(+) ATPase-alpha1 in the prefrontal cortex of subjects with schizophrenia. Schizophr Res 128:7–14Google Scholar
  34. Curtis D, Vine AE, McQuillin A, Bass NJ, Pereira A, Kandaswamy R, Lawrence J, Anjorin A, Choudhury K, Datta SR, Puri V, Krasucki R, Pimm J, Thirumalai S, Quested D, Gurling HM (2011) Case-case genome-wide association analysis shows markers differentially associated with schizophrenia and bipolar disorder and implicates calcium channel genes. Psychiatr Genet 21:1–4PubMedCrossRefGoogle Scholar
  35. Dai S, Hall DD, Hell JW (2009) Supramolecular assemblies and localized regulation of voltage-gated ion channels. Physiol Rev 89:411–452PubMedCrossRefGoogle Scholar
  36. Daniel C, Ohman M (2009) RNA editing and its impact on GABAA receptor function. Biochem Soc Trans 37:1399–1403PubMedCrossRefGoogle Scholar
  37. Dekeyne A, Millan MJ (2003) Discriminative stimulus properties of antidepressant agents: a review. Behav Pharmacol 14:391–407PubMedGoogle Scholar
  38. Dib-Hajj SD, Waxman SG (2010) Isoform-specific and pan-channel partners regulate trafficking and plasma membrane stability; and alter sodium channel gating properties. Neurosci Lett 486:84–91PubMedCrossRefGoogle Scholar
  39. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB (2010) Rare variants create synthetic genome-wide associations. PLoS Biol 8:e1000294PubMedCrossRefGoogle Scholar
  40. Dror V, Shamir E, Ghanshani S, Kimhi R, Swartz M, Barak Y, Weizman R, Avivi L, Litmanovitch T, Fantino E, Kalman K, Jones EG, Chandy KG, Gargus JJ, Gutman GA, Navon R (1999) hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21. Mol Psychiatry 4:254–260PubMedCrossRefGoogle Scholar
  41. Du W, Bautista JF, Yang H, Diez-Sampedro A, You SA, Wang L, Kotagal P, Luders HO, Shi J, Cui J, Richerson GB, Wang QK (2005) Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat Genet 37:733–738PubMedCrossRefGoogle Scholar
  42. Duncan CE, Chetcuti AF, Schofield PR (2008) Coregulation of genes in the mouse brain following treatment with clozapine, haloperidol, or olanzapine implicates altered potassium channel subunit expression in the mechanism of antipsychotic drug action. Psychiatr Genet 18:226–239PubMedCrossRefGoogle Scholar
  43. Farley IJ, Price KS, McCullough E, Deck JH, Hordynski W, Hornykiewicz O (1978) Norepinephrine in chronic paranoid schizophrenia: above-normal levels in limbic forebrain. Science 200:456–458PubMedCrossRefGoogle Scholar
  44. Fedorenko O, Strutz-Seebohm N, Henrion U, Ureche ON, Lang F, Seebohm G, Lang UE (2008) A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels. Psychopharmacology (Berl) 199:47–54CrossRefGoogle Scholar
  45. Fernandez-Alacid L, Aguado C, Ciruela F, Martin R, Colon J, Cabanero MJ, Gassmann M, Watanabe M, Shigemoto R, Wickman K, Bettler B, Sanchez-Prieto J, Lujan R (2009) Subcellular compartment-specific molecular diversity of pre- and post-synaptic GABA-activated GIRK channels in Purkinje cells. J Neurochem 110:1363–1376PubMedCrossRefGoogle Scholar
  46. Ferreira MA, O’Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K, Hamshere ML, Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS, Franklin J, Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C, Blumenstiel B, Defelice M, Breen G, Gill M, Morris DW, Elkin A, Muir WJ, McGhee KA, Williamson R, MacIntyre DJ, MacLean AW, St CD, Robinson M, Van Beck M, Pereira AC, Kandaswamy R, McQuillin A, Collier DA, Bass NJ, Young AH, Lawrence J, Ferrier IN, Anjorin A, Farmer A, Curtis D, Scolnick EM, McGuffin P, Daly MJ, Corvin AP, Holmans PA, Blackwood DH, Gurling HM, Owen MJ, Purcell SM, Sklar P, Craddock N (2008) Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40:1056–1058PubMedCrossRefGoogle Scholar
  47. Freudenberg J, Fu YH, Ptacek LJ (2007) Bioinformatic analysis of human CNS-expressed ion channels as candidates for episodic nervous system disorders. Neurogenetics 8:159–168PubMedCrossRefGoogle Scholar
  48. Fujiwara H, Hirao K, Namiki C, Yamada M, Shimizu M, Fukuyama H, Hayashi T, Murai T (2007) Anterior cingulate pathology and social cognition in schizophrenia: a study of gray matter, white matter and sulcal morphometry. Neuroimage 36:1236–1245PubMedCrossRefGoogle Scholar
  49. Gaddum JH, Hameed KA (1954) Drugs which antagonize 5-hydroxytryptamine. Br J Pharmacol Chemother 9:240–248PubMedGoogle Scholar
  50. Gaudet R (2007) Structural insights into the function of TRP channels. In: Liedtke WB, Heller S (eds) Frontiers in Neuroscience. CRC Press, Boca Raton, FLGoogle Scholar
  51. Glatt SJ, Faraone SV, Tsuang MT (2003) Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry 8:911–915PubMedCrossRefGoogle Scholar
  52. Glessner JT, Reilly MP, Kim CE, Takahashi N, Albano A, Hou C, Bradfield JP, Zhang H, Sleiman PM, Flory JH, Imielinski M, Frackelton EC, Chiavacci R, Thomas KA, Garris M, Otieno FG, Davidson M, Weiser M, Reichenberg A, Davis KL, Friedman JI, Cappola TP, Margulies KB, Rader DJ, Grant SF, Buxbaum JD, Gur RE, Hakonarson H (2010) Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci USA 107:10584–10589PubMedCrossRefGoogle Scholar
  53. Goetz T, Arslan A, Wisden W, Wulff P (2007) GABA(A) receptors: structure and function in the basal ganglia. Prog Brain Res 160:21–41PubMedCrossRefGoogle Scholar
  54. Gorlov IP, Gorlova OY, Sunyaev SR, Spitz MR, Amos CI (2008) Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet 82:100–112PubMedCrossRefGoogle Scholar
  55. Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I, Moretti M, Pedrazzi P, Pucci L, Zoli M (2009) Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol 78:703–711PubMedCrossRefGoogle Scholar
  56. Green EK, Grozeva D, Jones I, Jones L, Kirov G, Caesar S, Gordon-Smith K, Fraser C, Forty L, Russell E, Hamshere ML, Moskvina V, Nikolov I, Farmer A, McGuffin P, Holmans PA, Owen MJ, O’Donovan MC, Craddock N (2010) The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 15:1016–1022PubMedCrossRefGoogle Scholar
  57. Hansen HH, Waroux O, Seutin V, Jentsch TJ, Aznar S, Mikkelsen JD (2008) Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS. J Physiol 586:1823–1832PubMedCrossRefGoogle Scholar
  58. Hashimoto K, Panchenko AR (2010) Mechanisms of protein oligomerization, the critical role of insertions and deletions in maintaining different oligomeric states. Proc Natl Acad Sci USA 107:20352–20357PubMedCrossRefGoogle Scholar
  59. Ho TC, Brown S, Serences JT (2009) Domain general mechanisms of perceptual decision making in human cortex. J Neurosci 29:8675–8687PubMedCrossRefGoogle Scholar
  60. Honore E (2008) Alternative translation initiation further increases the molecular and functional diversity of ion channels. J Physiol 586:5605–5606PubMedCrossRefGoogle Scholar
  61. Huffaker SJ, Chen J, Nicodemus KK, Sambataro F, Yang F, Mattay V, Lipska BK, Hyde TM, Song J, Rujescu D, Giegling I, Mayilyan K, Proust MJ, Soghoyan A, Caforio G, Callicott JH, Bertolino A, Meyer-Lindenberg A, Chang J, Ji Y, Egan MF, Goldberg TE, Kleinman JE, Lu B, Weinberger DR (2009) A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med 15:509–518PubMedCrossRefGoogle Scholar
  62. ISC ISC (2008) Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455:237–241CrossRefGoogle Scholar
  63. Jegla TJ, Zmasek CM, Batalov S, Nayak SK (2009) Evolution of the human ion channel set. Comb Chem High Throughput Screen 12:2–23PubMedCrossRefGoogle Scholar
  64. Jenkinson DH (2006) Potassium channels—multiplicity and challenges. Br J Pharmacol 147(Suppl 1):S63–S71PubMedGoogle Scholar
  65. Jensen AA, Davies PA, Brauner-Osborne H, Krzywkowski K (2008) 3B but which 3B and that’s just one of the questions: the heterogeneity of human 5-HT3 receptors. Trends Pharmacol Sci 29:437–444PubMedCrossRefGoogle Scholar
  66. Joober R, Benkelfat C, Brisebois K, Toulouse A, Lafreniere RG, Turecki G, Lal S, Bloom D, Labelle A, Lalonde P, Fortin D, Alda M, Palmour R, Rouleau GA (1999) Lack of association between the hSKCa3 channel gene CAG polymorphism and schizophrenia. Am J Med Genet 88:154–157PubMedCrossRefGoogle Scholar
  67. Judge SI, Smith PJ, Stewart PE, Bever CT Jr (2007) Potassium channel blockers and openers as CNS neurologic therapeutic agents. Recent Pat CNS Drug Discov 2:200–228PubMedCrossRefGoogle Scholar
  68. Kapfhamer D, Berger KH, Hopf FW, Seif T, Kharazia V, Bonci A, Heberlein U (2010) Protein Phosphatase 2a and glycogen synthase kinase 3 signaling modulate prepulse inhibition of the acoustic startle response by altering cortical M-Type potassium channel activity. J Neurosci 30:8830–8840PubMedCrossRefGoogle Scholar
  69. Keshavan MS, Sanders RD, Sweeney JA, Diwadkar VA, Goldstein G, Pettegrew JW, Schooler NR (2003) Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry 160:1298–1304PubMedCrossRefGoogle Scholar
  70. Krause M, Offermanns S, Stocker M, Pedarzani P (2002) Functional specificity of G alpha q and G alpha 11 in the cholinergic and glutamatergic modulation of potassium currents and excitability in hippocampal neurons. J Neurosci 22:666–673PubMedGoogle Scholar
  71. Kurokawa J, Bankston JR, Kaihara A, Chen L, Furukawa T, Kass RS (2009) KCNE variants reveal a critical role of the beta subunit carboxyl terminus in PKA-dependent regulation of the IKs potassium channel. Channels (Austin) 3:16–24Google Scholar
  72. Lachowicz JE, Sibley DR (1997) Molecular characteristics of mammalian dopamine receptors. Pharmacol Toxicol 81:105–113PubMedCrossRefGoogle Scholar
  73. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J (2007) Molecular mechanisms of schizophrenia. Cell Physiol Biochem 20:687–702PubMedCrossRefGoogle Scholar
  74. Levitan IB (2006) Signaling protein complexes associated with neuronal ion channels. Nat Neurosci 9:305–310PubMedCrossRefGoogle Scholar
  75. Li T, Hu X, Chandy KG, Fantino E, Kalman K, Gutman G, Gargus JJ, Freeman B, Murray RM, Dawson E, Liu X, Bruinvels AT, Sham PC, Collier DA (1998) Transmission disequilibrium analysis of a triplet repeat within the hKCa3 gene using family trios with schizophrenia. Biochem Biophys Res Commun 251:662–665PubMedCrossRefGoogle Scholar
  76. Lin WH, Wright DE, Muraro NI, Baines RA (2009) Alternative splicing in the voltage-gated sodium channel DmNav regulates activation, inactivation, and persistent current. J Neurophysiol 102:1994–2006PubMedCrossRefGoogle Scholar
  77. MacDonald AW 3rd, Carter CS, Kerns JG, Ursu S, Barch DM, Holmes AJ, Stenger VA, Cohen JD (2005) Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis. Am J Psychiatry 162:475–484PubMedCrossRefGoogle Scholar
  78. Marionneau C, Townsend RR, Nerbonne JM (2011) Proteomic analysis highlights the molecular complexities of native Kv4 channel macromolecular complexes. Semin Cell Dev Biol 22:145–152PubMedCrossRefGoogle Scholar
  79. McCarroll SA (2008) Extending genome-wide association studies to copy-number variation. Hum Mol Genet 17:R135–R142PubMedCrossRefGoogle Scholar
  80. McClellan JM, Susser E, King MC (2007) Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry 190:194–199PubMedCrossRefGoogle Scholar
  81. Mechaly I, Scamps F, Chabbert C, Sans A, Valmier J (2005) Molecular diversity of voltage-gated sodium channel alpha subunits expressed in neuronal and non-neuronal excitable cells. Neuroscience 130:389–396PubMedCrossRefGoogle Scholar
  82. Medina I, Montaner D, Bonifaci N, Pujana MA, Carbonell J, Tarraga J, Al-Shahrour F, Dopazo J (2009) Gene set-based analysis of polymorphisms: finding pathways or biological processes associated to traits in genome-wide association studies. Nucleic Acids Res 37:W340–W344PubMedCrossRefGoogle Scholar
  83. Meltzer HY, Roth B (1995) The role of serotonin in schizophrenia. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York. http://www.acnp.org/g4/GN40100011/Default.htm
  84. Miller MJ, Rauer H, Tomita H, Gargus JJ, Gutman GA, Cahalan MD, Chandy KG (2001) Nuclear localization and dominant-negative suppression by a mutant SKCa3 N-terminal channel fragment identified in a patient with schizophrenia. J Biol Chem 276:27753–27756PubMedCrossRefGoogle Scholar
  85. Milstein AD, Zhou W, Karimzadegan S, Bredt DS, Nicoll RA (2007) TARP subtypes differentially and dose-dependently control synaptic AMPA receptor gating. Neuron 55:905–918PubMedCrossRefGoogle Scholar
  86. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189–225PubMedGoogle Scholar
  87. Miyamoto S, LaMantia AS, Duncan GE, Sullivan P, Gilmore JH, Lieberman JA (2003) Recent advances in the neurobiology of schizophrenia. Mol Interv 3:27–39PubMedCrossRefGoogle Scholar
  88. Mohapatra DP, Park KS, Trimmer JS (2007) Dynamic regulation of the voltage-gated Kv2.1 potassium channel by multisite phosphorylation. Biochem Soc Trans 35:1064–1068PubMedCrossRefGoogle Scholar
  89. Molina ML, Barrera FN, Fernandez AM, Poveda JA, Renart ML, Encinar JA, Riquelme G, Gonzalez-Ros JM (2006) Clustering and coupled gating modulate the activity in KcsA, a potassium channel model. J Biol Chem 281:18837–18848PubMedCrossRefGoogle Scholar
  90. Moore JH, Williams SM (2005) Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis. Bioessays 27:637–646PubMedCrossRefGoogle Scholar
  91. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, Barney N, White BC (2006) A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 241:252–261PubMedCrossRefGoogle Scholar
  92. Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E, Owen MJ, O’Donovan MC (2009) Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 14:252–260PubMedCrossRefGoogle Scholar
  93. Nam D, Kim J, Kim SY, Kim S (2010) GSA-SNP: a general approach for gene set analysis of polymorphisms. Nucleic Acids Res 38:W749–W754PubMedCrossRefGoogle Scholar
  94. Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL, Shianna KV, Yoon W, Kasperaviciute D, Gennarelli M, Strittmatter WJ, Bonvicini C, Rossi G, Jayathilake K, Cola PA, McEvoy JP, Keefe RS, Fisher EM, St Jean PL, Giegling I, Hartmann AM, Moller HJ, Ruppert A, Fraser G, Crombie C, Middleton LT, St Clair D, Roses AD, Muglia P, Francks C, Rujescu D, Meltzer HY, Goldstein DB (2009) A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet 5:e1000373PubMedCrossRefGoogle Scholar
  95. Neighbors HW, Trierweiler SJ, Ford BC, Muroff JR (2003) Racial differences in DSM diagnosis using a semi-structured instrument: the importance of clinical judgment in the diagnosis of African Americans. J Health Soc Behav 44:237–256PubMedCrossRefGoogle Scholar
  96. Nicoll RA (1988) The coupling of neurotransmitter receptors to ion channels in the brain. Science 241:545–551PubMedCrossRefGoogle Scholar
  97. Nigg JT, Casey BJ (2005) An integrative theory of attention-deficit/hyperactivity disorder based on the cognitive and affective neurosciences. Dev Psychopathol 17:785–806PubMedGoogle Scholar
  98. Nudmamud-Thanoi S, Piyabhan P, Harte MK, Cahir M, Reynolds GP (2007) Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia. J Neural Transm Suppl (72):281–285Google Scholar
  99. Nyegaard M, Demontis D, Foldager L, Hedemand A, Flint TJ, Sorensen KM, Andersen PS, Nordentoft M, Werge T, Pedersen CB, Hougaard DM, Mortensen PB, Mors O, Borglum AD (2010) CACNA1C (rs1006737) is associated with schizophrenia. Mol Psychiatry 15:119–121PubMedCrossRefGoogle Scholar
  100. Olsen RW, Sieghart W (2009) GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56:141–148PubMedCrossRefGoogle Scholar
  101. Paoletti P (2011) Molecular basis of NMDA receptor functional diversity. Eur J Neurosci 33(8):1351–1365PubMedCrossRefGoogle Scholar
  102. Papassotiropoulos A, Henke K, Stefanova E, Aerni A, Muller A, Demougin P, Vogler C, Sigmund JC, Gschwind L, Huynh KD, Coluccia D, Mondadori CR, Hanggi J, Buchmann A, Kostic V, Novakovic I, van den Bussche H, Kaduszkiewicz H, Weyerer S, Bickel H, Riedel-Heller S, Pentzek M, Wiese B, Dichgans M, Wagner M, Jessen F, Maier W, de Quervain DJ (2011) A genome-wide survey of human short-term memory. Mol Psychiatry 16:184–192PubMedCrossRefGoogle Scholar
  103. Paquette J, Tokuyasu T (2010) EGAN: exploratory gene association networks. Bioinformatics 26:285–286PubMedCrossRefGoogle Scholar
  104. Pavuluri MN, O’Connor MM, Harral E, Sweeney JA (2007) Affective neural circuitry during facial emotion processing in pediatric bipolar disorder. Biol Psychiatry 62:158–167PubMedCrossRefGoogle Scholar
  105. Perlstein WM, Carter CS, Noll DC, Cohen JD (2001) Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am J Psychiatry 158:1105–1113PubMedCrossRefGoogle Scholar
  106. Perrais D, Veran J, Mulle C (2010) Gating and permeation of kainate receptors: differences unveiled. Trends Pharmacol Sci 31:516–522PubMedCrossRefGoogle Scholar
  107. Petryshen TL, Middleton FA, Tahl AR, Rockwell GN, Purcell S, Aldinger KA, Kirby A, Morley CP, McGann L, Gentile KL, Waggoner SG, Medeiros HM, Carvalho C, Macedo A, Albus M, Maier W, Trixler M, Eichhammer P, Schwab SG, Wildenauer DB, Azevedo MH, Pato MT, Pato CN, Daly MJ, Sklar P (2005) Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry 10:1074–1088 1057PubMedCrossRefGoogle Scholar
  108. Picton AJ, Fisher JL (2007) Effect of the alpha subunit subtype on the macroscopic kinetic properties of recombinant GABA(A) receptors. Brain Res 1165:40–49PubMedCrossRefGoogle Scholar
  109. Province MA (2001) The significance of not finding a gene. Am J Hum Genet 69:660–663PubMedCrossRefGoogle Scholar
  110. Reif DM, Dudek SM, Shaffer CM, Wang J, Moore JH (2005) Exploratory visual analysis of pharmacogenomic results. Pac Symp Biocomput:296–307Google Scholar
  111. Reif DM, Israel MA, Moore JH (2007) Exploratory visual analysis of statistical results from microarray experiments comparing high and low grade glioma. Cancer Inform 5:19–24PubMedGoogle Scholar
  112. Reynolds GP, Harte MK (2007) The neuronal pathology of schizophrenia: molecules and mechanisms. Biochem Soc Trans 35:433–436PubMedCrossRefGoogle Scholar
  113. Ritsner M, Modai I, Ziv H, Amir S, Halperin T, Weizman A, Navon R (2002) An association of CAG repeats at the KCNN3 locus with symptom dimensions of schizophrenia. Biol Psychiatry 51:788–794PubMedCrossRefGoogle Scholar
  114. Rohrmeier T, Putzhammer A, Schoeler A, Sartor H, Dallinger P, Nothen MM, Propping P, Knapp M, Albus M, Borrmann M, Knothe K, Kreiner R, Franzek E, Lichtermann D, Rietschel M, Maier W, Klein HE, Eichhammer P (1999) hSKCa3: no association of the polymorphic CAG repeat with bipolar affective disorder and schizophrenia. Psychiatr Genet 9:169–175PubMedCrossRefGoogle Scholar
  115. Russell A, Cortese B, Lorch E, Ivey J, Banerjee SP, Moore GJ, Rosenberg DR (2003) Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 13(Suppl 1):S31–S38PubMedCrossRefGoogle Scholar
  116. Sailer CA, Kaufmann WA, Marksteiner J, Knaus HG (2004) Comparative immunohistochemical distribution of three small-conductance Ca2+-activated potassium channel subunits, SK1, SK2, and SK3 in mouse brain. Mol Cell Neurosci 26:458–469PubMedCrossRefGoogle Scholar
  117. Saleem Q, Sreevidya VS, Sudhir J, Savithri JV, Gowda Y, BR C, Benegal V, Majumder PP, Anand A, Brahmachari SK, Jain S (2000) Association analysis of CAG repeats at the KCNN3 locus in Indian patients with bipolar disorder and schizophrenia. Am J Med Genet 96:744–748PubMedCrossRefGoogle Scholar
  118. Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522PubMedGoogle Scholar
  119. Schulze TG, Detera-Wadleigh SD, Akula N, Gupta A, Kassem L, Steele J, Pearl J, Strohmaier J, Breuer R, Schwarz M, Propping P, Nothen MM, Cichon S, Schumacher J, Rietschel M, McMahon FJ (2009) Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry 14:487–491PubMedCrossRefGoogle Scholar
  120. Sidak Z (1967) Rectangular confidence region for the means of multivariate normal distributions. J Am Stat Assoc 62:626–633CrossRefGoogle Scholar
  121. Silbersweig DA, Stern E (1998) Towards a functional neuroanatomy of conscious perception and its modulation by volition: implications of human auditory neuroimaging studies. Philos Trans R Soc Lond B Biol Sci 353:1883–1888PubMedCrossRefGoogle Scholar
  122. Singer T (2007) The neuronal basis of empathy and fairness. Novartis Found Symp 278:20–30 discussion 30–40, 89–96, 216–221PubMedCrossRefGoogle Scholar
  123. Siuta MA, Robertson SD, Kocalis H, Saunders C, Gresch PJ, Khatri V, Shiota C, Kennedy JP, Lindsley CW, Daws LC, Polley DB, Veenstra-Vanderweele J, Stanwood GD, Magnuson MA, Niswender KD, Galli A (2010) Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol 8:e1000393PubMedCrossRefGoogle Scholar
  124. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH, Gurling HM, Purcell SM (2008) Whole-genome association study of bipolar disorder. Mol Psychiatry 13:558–569PubMedCrossRefGoogle Scholar
  125. Sotty F, Damgaard T, Montezinho LP, Mork A, Olsen CK, Bundgaard C, Husum H (2009) Antipsychotic-like effect of retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission. J Pharmacol Exp Ther 328:951–962PubMedCrossRefGoogle Scholar
  126. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, Fossdal R, Sigurdsson E, Sigmundsson T, Buizer-Voskamp JE, Hansen T, Jakobsen KD, Muglia P, Francks C, Matthews PM, Gylfason A, Halldorsson BV, Gudbjartsson D, Thorgeirsson TE, Sigurdsson A, Jonasdottir A, Bjornsson A, Mattiasdottir S, Blondal T, Haraldsson M, Magnusdottir BB, Giegling I, Moller HJ, Hartmann A, Shianna KV, Ge D, Need AC, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Paunio T, Toulopoulou T, Bramon E, Di Forti M, Murray R, Ruggeri M, Vassos E, Tosato S, Walshe M, Li T, Vasilescu C, Muhleisen TW, Wang AG, Ullum H, Djurovic S, Melle I, Olesen J, Kiemeney LA, Franke B, Sabatti C, Freimer NB, Gulcher JR, Thorsteinsdottir U, Kong A, Andreassen OA, Ophoff RA, Georgi A, Rietschel M, Werge T, Petursson H, Goldstein DB, Nothen MM, Peltonen L, Collier DA, St Clair D, Stefansson K (2008) Large recurrent microdeletions associated with schizophrenia. Nature 455:232–236PubMedCrossRefGoogle Scholar
  127. Sternberg DE, Charney DS, Heninger GR, Leckman JF, Hafstad KM, Landis DH (1982) Impaired presynaptic regulation of norepinephrine in schizophrenia. Effects of clonidine in schizophrenic patients and normal controls. Arch Gen Psychiatry 39:285–289PubMedCrossRefGoogle Scholar
  128. Stober G, Jatzke S, Meyer J, Okladnova O, Knapp M, Beckmann H, Lesch KP (1998) Short CAG repeats within the hSKCa3 gene associated with schizophrenia: results of a family-based study. Neuroreport 9:3595–3599PubMedCrossRefGoogle Scholar
  129. Stober G, Meyer J, Nanda I, Wienker TF, Saar K, Jatzke S, Schmid M, Lesch KP, Beckmann H (2000) hKCNN3 which maps to chromosome 1q21 is not the causative gene in periodic catatonia, a familial subtype of schizophrenia. Eur Arch Psychiatry Clin Neurosci 250:163–168PubMedCrossRefGoogle Scholar
  130. Stocker M (2004) Ca2+-activated K+ channels: molecular determinants and function of the SK family. Nature Rev Neurosci 5:758–770CrossRefGoogle Scholar
  131. Stocker M, Hirzel K, D’hoedt D, Pedarzani P (2004) Matching molecules to function: neuronal Ca2+-activated K+ channels and afterhyperpolarizations. Toxicon 43:933–949PubMedCrossRefGoogle Scholar
  132. Strong M, Gutman GA (1993) Missing link in ion channels. Nature 362:26PubMedCrossRefGoogle Scholar
  133. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545–15550PubMedCrossRefGoogle Scholar
  134. Tam GW, van de Lagemaat LN, Redon R, Strathdee KE, Croning MD, Malloy MP, Muir WJ, Pickard BS, Deary IJ, Blackwood DH, Carter NP, Grant SG (2010) Confirmed rare copy number variants implicate novel genes in schizophrenia. Biochem Soc Trans 38:445–451PubMedCrossRefGoogle Scholar
  135. Thompson J, Begenisich T (2006) Membrane-delimited inhibition of maxi-K channel activity by the intermediate conductance Ca2+-activated K channel. J Gen Physiol 127:159–169PubMedCrossRefGoogle Scholar
  136. Thornton-Wells TA, Moore JH, Haines JL (2004) Genetics, statistics and human disease: analytical retooling for complexity. Trends Genet 20:640–647PubMedCrossRefGoogle Scholar
  137. Thummler S, Duprat F, Lazdunski M (2007) Antipsychotics inhibit TREK but not TRAAK channels. Biochem Biophys Res Commun 354:284–289PubMedCrossRefGoogle Scholar
  138. Tishkoff SA, Williams SM (2002) Genetic analysis of African populations: human evolution and complex disease. Nat Rev Genet 3:611–621PubMedCrossRefGoogle Scholar
  139. Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, Froment A, Hirbo JB, Awomoyi AA, Bodo JM, Doumbo O, Ibrahim M, Juma AT, Kotze MJ, Lema G, Moore JH, Mortensen H, Nyambo TB, Omar SA, Powell K, Pretorius GS, Smith MW, Thera MA, Wambebe C, Weber JL, Williams SM (2009) The genetic structure and history of Africans and African Americans. Science 324:1035–1044PubMedCrossRefGoogle Scholar
  140. Trierweiler SJ, Neighbors HW, Munday C, Thompson EE, Binion VJ, Gomez JP (2000) Clinician attributions associated with the diagnosis of schizophrenia in African American and non-African American patients. J Consult Clin Psychol 68:171–175PubMedCrossRefGoogle Scholar
  141. Trierweiler SJ, Neighbors HW, Munday C, Thompson EE, Jackson JS, Binion VJ (2006) Differences in patterns of symptom attribution in diagnosing schizophrenia between African American and non-African American clinicians. Am J Orthopsychiatry 76:154–160PubMedCrossRefGoogle Scholar
  142. Trimmer JS, Rhodes KJ (2004) Localization of voltage-gated ion channels in mammalian brain. Annu Rev Physiol 66:477–519PubMedCrossRefGoogle Scholar
  143. Tseng TT, McMahon AM, Johnson VT, Mangubat EZ, Zahm RJ, Pacold ME, Jakobsson E (2007) Sodium channel auxiliary subunits. J Mol Microbiol Biotechnol 12:249–262PubMedCrossRefGoogle Scholar
  144. Ujike H, Yamamoto A, Tanaka Y, Takehisa Y, Takaki M, Taked T, Kodama M, Kuroda S (2001) Association study of CAG repeats in the KCNN3 gene in Japanese patients with schizophrenia, schizoaffective disorder and bipolar disorder. Psychiatry Res 101:203–207PubMedCrossRefGoogle Scholar
  145. Van Schijndel JE, Martens JM (2010) Gene expression profiling in rodent models for schizophrenia. Current Neuropharmacol 8:382–393CrossRefGoogle Scholar
  146. Vanoye CG, Welch RC, Tian C, Sanders CR, George AL Jr (2010) KCNQ1/KCNE1 assembly, co-translation not required. Channels (Austin) 4:108–114Google Scholar
  147. Vazquez E, Valverde MA (2006) A review of TRP channels splicing. Semin Cell Dev Biol 17:607–617PubMedCrossRefGoogle Scholar
  148. Verhoeff NP (1999) Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders. Psychopharmacology (Berl) 147:217–249CrossRefGoogle Scholar
  149. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King MC, Sebat J (2008) Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320:539–543PubMedCrossRefGoogle Scholar
  150. Wang K, Li M, Bucan M (2007) Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 81(6):1278–1283PubMedCrossRefGoogle Scholar
  151. Wang K, Dickson SP, Stolle CA, Krantz ID, Goldstein DB, Hakonarson H (2010) Interpretation of association signals and identification of causal variants from genome-wide association studies. Am J Hum Genet 86:730–742PubMedCrossRefGoogle Scholar
  152. Waxman SG (2000) The neuron as a dynamic electrogenic machine: modulation of sodium-channel expression as a basis for functional plasticity in neurons. Philos Trans R Soc Lond B Biol Sci 355:199–213PubMedCrossRefGoogle Scholar
  153. Waxman SG (2007) Channel, neuronal and clinical function in sodium channelopathies: from genotype to phenotype. Nat Neurosci 10:405–409PubMedCrossRefGoogle Scholar
  154. Waxman SG, Dib-Hajj S, Cummins TR, Black JA (2000) Sodium channels and their genes: dynamic expression in the normal nervous system, dysregulation in disease states(1). Brain Res 886:5–14PubMedCrossRefGoogle Scholar
  155. Wei J, Hemmings GP (2006) A further study of a possible locus for schizophrenia on the X chromosome. Biochem Biophys Res Commun 344:1241–1245PubMedCrossRefGoogle Scholar
  156. Wise CD, Stein L (1973) Dopamine-beta-hydroxylase deficits in the brains of schizophrenic patients. Science 181:344–347PubMedCrossRefGoogle Scholar
  157. Wittekindt O, Jauch A, Burgert E, Scharer L, Holtgreve-Grez H, Yvert G, Imbert G, Zimmer J, Hoehe MR, Macher JP, Chiaroni P, van Calker D, Crocq MA, Morris-Rosendahl DJ (1998) The human small conductance calcium-regulated potassium channel gene (hSKCa3) contains two CAG repeats in exon 1, is on chromosome 1q21.3, and shows a possible association with schizophrenia. Neurogenetics 1:259–265PubMedCrossRefGoogle Scholar
  158. Wolfart J, Neuhoff H, Franz O, Roeper J (2001) Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. J Neurosci 21:3443–3456PubMedGoogle Scholar
  159. Wong AH, Lipska BK, Likhodi O, Boffa E, Weinberger DR, Kennedy JL, Van Tol HH (2005) Cortical gene expression in the neonatal ventral-hippocampal lesion rat model. Schizophr Res 77:261–270PubMedCrossRefGoogle Scholar
  160. Woolley DW, Shaw E (1954) A biochemical and pharmacological suggestion about certain mental disorders. Proc Natl Acad Sci USA 40:228–231PubMedCrossRefGoogle Scholar
  161. Xiao Z, Deng PY, Rojanathammanee L, Yang C, Grisanti L, Permpoonputtana K, Weinshenker D, Doze VA, Porter JE, Lei S (2009) Noradrenergic depression of neuronal excitability in the entorhinal cortex via activation of TREK-2K+ channels. J Biol Chem 284:10980–10991PubMedCrossRefGoogle Scholar
  162. Xie M, Holmqvist MH, Hsia AY (2004) Ion channel drug discovery expands into new disease areas. pp 31–33. http://www.pdfio.com/k-647071.html#
  163. Yan J, Olsen JV, Park KS, Li W, Bildl W, Schulte U, Aldrich RW, Fakler B, Trimmer JS (2008) Profiling the phospho-status of the BKCa channel alpha subunit in rat brain reveals unexpected patterns and complexity. Mol Cell Proteomics 7:2188–2198PubMedCrossRefGoogle Scholar
  164. Yang KC, Jin GZ, Wu J (2009) Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology. Acta Pharmacol Sin 30:740–751PubMedCrossRefGoogle Scholar
  165. Zaykin DV, Zhivotovsky LA, Westfall PH, Weir BS (2002) Truncated product method for combining P-values. Genet Epidemiol 22:170–185PubMedCrossRefGoogle Scholar
  166. Zhang K, Cui S, Chang S, Zhang L, Wang J (2010) i-GSEA4GWAS: a web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study. Nucleic Acids Res 38:W90–W95PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Kathleen Askland
    • 1
  • Cynthia Read
    • 1
  • Chloe O’Connell
    • 2
  • Jason H. Moore
    • 3
  1. 1.Department of Psychiatry and Human BehaviorButler Hospital, Brown UniversityProvidenceUSA
  2. 2.Brown UniversityProvidenceUSA
  3. 3.Departments of Genetics and Community and Family MedicineInstitute for Quantitative Biomedical Sciences, Dartmouth CollegeLebanonUSA

Personalised recommendations